Long-term outcomes of extending dual antiplatelet therapy after drug-eluting stent implantation for acute coronary syndrome: a large single-center study
To date, DAPT duration of 1 year is the standard treatment for ACS patients after DES implantation in China. However, less is known about the effect of prolonging DAPT duration of long-term outcome for this kind of patient in the real world of China. We carried out a large sample case in the biggest...
Main Authors: | Jingjing Xu, Ying Song, Zhan Gao, Ping Jiang, Ru Liu, Huanhuan Wang, Shubin Qiao, Runlin Gao, Yuejin Yang, Bo Xu, Jinqing Yuan |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-10-01
|
Series: | Platelets |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09537104.2019.1693036 |
Similar Items
-
Long‐Term Outcomes and Duration of Dual Antiplatelet Therapy After Coronary Intervention With Second‐Generation Drug‐Eluting Stents: The Veterans Affairs Extended DAPT Study
by: Scott Kinlay, et al.
Published: (2023-01-01) -
Trends in dual antiplatelet therapy regimens and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention with drug‐eluting stents: A multicenter real‐world study
by: Preyanate Wilairat, et al.
Published: (2025-03-01) -
Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients
by: Jialun Han, et al.
Published: (2023-03-01) -
Drug-eluting stents for coronary artery disease in the perspective of bibliometric analysis
by: Ying Zeng, et al.
Published: (2024-02-01) -
The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2019-05-01)